Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02813083 · ClinicalTrials.gov registry record
Detection of Pathological Lymphocytes in Patients With Autoimmune Disease
A clinical trial, sponsored by University of Minnesota.
- Completed
- Registry status
- 129
- Enrollment target
NCT02813083 is a clinical trial that has completed, run by University of Minnesota. The registered enrollment target is 129 participants.
The verdict
NCT02813083 has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- 129 participants
- Enrollment target
Study Summary
This study will help the investigators design a method to detect the disease-causing immune cells in patients with rheumatoid arthritis (RA). Such methods are not currently available, but if successful, would help scientists to better understand the causes of RA.
Interventions
- OTHER No intervention (observational)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 129 participants |
| Start Date | 2011-08 |
| Est. Completion | 2023-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02813083
The ClinicalTrials.gov registry entry for NCT02813083 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 129 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which No intervention (observational) is the first listed.
NCT02813083 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02813083 about?
NCT02813083 is a clinical study titled "Detection of Pathological Lymphocytes in Patients With Autoimmune Disease". This study will help the investigators design a method to detect the disease-causing immune cells in patients with rheumatoid arthritis (RA). Such methods are not currently available, but if successful, would help scientists to better understand the causes of RA.
What is the current status of trial NCT02813083?
This trial is currently completed. The enrollment target is 129 participants. The study started on 2011-08. Estimated completion is 2023-09.
What interventions are being tested in trial NCT02813083?
The interventions under investigation include: No intervention (observational) (OTHER).
Who is sponsoring clinical trial NCT02813083?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.